Paper36923533
Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease.
Yin T and 9 others. Theranostics, 2023. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease. Papers, record 36923533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923533
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Extracellular Vesicles | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Humans | |
| Aging | |
| Cell Communication |
Source PubMed
References200
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31995983 | Acoustic Immunosensing of Exosomes Using a Quartz Crystal Microbalance with Dissipation Monitoring. | Anal Chem | 2020 | https://conductscience.org/library/papers/31995983 | PubMed |
| 2 | 31728485 | Biomimetic drug-delivery systems for the management of brain diseases. | Biomater Sci | 2020 | https://conductscience.org/library/papers/31728485 | PubMed |
| 3 | 35501833 | Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue/cell source and culture conditions. | Cell Biosci | 2022 | https://conductscience.org/library/papers/35501833 | PubMed |
| 4 | 31275145 | MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents? | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31275145 | PubMed |
| 5 | 29334272 | Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds. | Drug Deliv | 2018 | https://conductscience.org/library/papers/29334272 | PubMed |
| 6 | 18462748 | Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. | J Mol Cell Cardiol | 2008 | https://conductscience.org/library/papers/18462748 | PubMed |
| 7 | 34485835 | The role of extracellular vesicles in the physiological and pathological regulation of the blood-brain barrier. | FASEB Bioadv | 2021 | https://conductscience.org/library/papers/34485835 | PubMed |
| 8 | 35071216 | Review on Strategies and Technologies for Exosome Isolation and Purification. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/35071216 | PubMed |
| 9 | 30992990 | Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. | Biomark Res | 2019 | https://conductscience.org/library/papers/30992990 | PubMed |
| 10 | 26754424 | MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. | Cell Commun Signal | 2016 | https://conductscience.org/library/papers/26754424 | PubMed |
| 11 | 29071676 | Analysis of Individual Extracellular Vesicles by Flow Cytometry. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29071676 | PubMed |
| 12 | 34678444 | MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease. | Brain Res Bull | 2021 | https://conductscience.org/library/papers/34678444 | PubMed |
| 13 | 30856179 | Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies. | PLoS One | 2019 | https://conductscience.org/library/papers/30856179 | PubMed |
| 14 | 27567840 | Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice. | J Alzheimers Dis | 2016 | https://conductscience.org/library/papers/27567840 | PubMed |
| 15 | 32020555 | Sodium Oligomannate: First Approval. | Drugs | 2020 | https://conductscience.org/library/papers/32020555 | PubMed |
| 16 | 33628730 | Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. | Front Oncol | 2020 | https://conductscience.org/library/papers/33628730 | PubMed |
| 17 | 34512767 | Mesenchymal Stem Cell Therapy for Alzheimer's Disease. | Stem Cells Int | 2021 | https://conductscience.org/library/papers/34512767 | PubMed |
| 18 | 25220352 | Surface functionalization of exosomes using click chemistry. | Bioconjug Chem | 2014 | https://conductscience.org/library/papers/25220352 | PubMed |
| 19 | 29085024 | Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. | Sci Rep | 2017 | https://conductscience.org/library/papers/29085024 | PubMed |
| 20 | 35204722 | Switching Roles: Beneficial Effects of Adipose Tissue-Derived Mesenchymal Stem Cells on Microglia and Their Implication in Neurodegenerative Diseases. | Biomolecules | 2022 | https://conductscience.org/library/papers/35204722 | PubMed |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943300 | Microglial Therapeutic Potential in Alzheimer's Disease: From Phenotypic Diversity to Targeted Interventions. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943300 | PubMed |
| 42891097 | Extracellular vesicles for Alzheimer's disease therapy: mechanisms, engineering strategies, and clinical translation. | Extracell Vesicles Circ Nucl Acids | 2026 | https://conductscience.org/library/papers/42891097 | PubMed |
| 42865955 | Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42865955 | PubMed |
| 42840442 | Mesenchymal stromal cells and paracrine modulation of neuroplasticity in the central nervous system. | EXCLI J | 2026 | https://conductscience.org/library/papers/42840442 | PubMed |
| 42720824 | Mesenchymal Stem Cell-Derived Exosomes for Alzheimer's Disease: Mechanisms, Preclinical Evidence, and Translational Challenges. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42720824 | PubMed |
| 42682864 | Imaging the therapeutic effects of cerebral endothelial cell derived exosome treatment of a preclinical model of Alzheimer's disease. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42682864 | PubMed |
| 42357346 | Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357346 | PubMed |
| 42222363 | Overcoming the blood-brain barrier in Alzheimer's disease: translational perspectives on advanced drug delivery platforms. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42222363 | PubMed |
| 42180524 | Extracellular vesicles: Revolutionizing targeted therapy for ischemic stroke. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42180524 | PubMed |
| 42039285 | Pathology-directed drug delivery strategies: How to overcome blood-brain barrier for the treatment of brain diseases. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039285 | PubMed |
| 41858793 | Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuroimmune interactions to intercellular communication. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41858793 | PubMed |
| 41847685 | Human umbilical cord mesenchymal stem cells therapy for Alzheimer's disease: a systematic review and meta-analysis of mouse models. | Front Neurol | 2026 | https://conductscience.org/library/papers/41847685 | PubMed |
| 41778730 | Targeted nanovesicular delivery of dexmedetomidine modulates microglial lysosomal function via Sirt3 signaling to ameliorate neurodegenerative pathology. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41778730 | PubMed |
| 41709314 | Exploiting the role of milk extracellular vesicles: a comprehensive analysis on isolation methods, characterization, surface modifications, and their therapeutic applications. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41709314 | PubMed |
| 41704086 | Uncovering the Healing Power of Stem Cells: Harnessing Regenerative Therapies for Alzheimer's Disease. | Curr Aging Sci | 2025 | https://conductscience.org/library/papers/41704086 | PubMed |
| 41622480 | Treatment of animal models of Alzheimer's disease with extracellular vesicles or exosomes and involvement of microRNAs. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41622480 | PubMed |
| 41452429 | An overview of gene and cell therapy approaches for Alzheimer's disease. | Metab Brain Dis | 2025 | https://conductscience.org/library/papers/41452429 | PubMed |
| 41417199 | EVs from Stem Cells Improve Mitochondrial Dysfunction in Neuronal Disorders. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41417199 | PubMed |
| 41408986 | Immuno-Regulation of Brain Region-Specific Organoids Containing Isogenic Microglia-Like Cells. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41408986 | PubMed |
| 41235241 | Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235241 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36923533
GET https://conductscience.org/api/papers/v1/36923533/references?page=2